Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Contraceptive Methods”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,171 records · Page 65Linked to original sources
PubMedDate not supplied

Age variation in use of a contraceptive service by adolescents.

During the past decade, much has been written about adolescents' use of contraception and their experience of pregnancy. Few researchers, however, have distinguished between the experiences of older and younger adolescents. The purpose of this paper is to provide such a comparison. The data were collected during more than 7,000 visits made by 4,318 patients during almost 5 years of operation of an adolescent contraceptive service in the Washington Heights area of New York City. Characteristics of four groups--14 years and younger, 15-17 years, 18-19 years, and 20-21 years--were examined. The youngest teens initiated sexual intercourse 4 years earlier than the oldest group. Among those 14 or younger, 87 percent had never used contraception, and 9 percent had been pregnant. In the oldest group, more than two-thirds had used a contraceptive method, and three-fifths had already experienced a pregnancy. Results of multivariate analyses indicate that older teens are more likely to come to the clinic for contraception and to be consistent users of the first method of contraception that they select. On the other hand, younger teens are significantly more likely to revisit the clinic and to be pregnant at a second or later visit.

Abortion, Induced↗
PubMed1991

The effect of ciprofloxacin on oral contraceptive steroid treatments.

The effect of ciprofloxacin, a new broad-spectrum quinolone derivative, on concomitant oral contraceptive steroids has been studied in a double-blind cross-over placebo-controlled randomized trial. Ten healthy women using long-term oral contraceptive steroids received either ciprofloxacin 500 mg BID or placebo during two consecutive cycles. Therapy was continued for seven days from the first day of contraceptive treatment. FSH, LH and oestradiol blood levels were repeatedly determined to monitor contraceptive steroid efficacy. A seven-day treatment with ciprofloxacin did not affect steroid treatment outcome and appears to be safe in women using this contraceptive method.

Adult↗
PubMedDate not supplied

Contraception during lactation.

Seven hundred and seventy-two lactating mothers were studied from delivery for 1 year to select the best contraceptive method (oral drug, injected drug, or IUD) which did not affect lactation. Ten groups of mothers were studied, including 234 control subjects. The injectable progestational contraceptives caused an improvement in the amount of milk and its protein concentration, whereas the IUCDs did not influence the lactation pattern. Sulpiride was an ineffective contraceptive but a potent lactation stimulant. The side effects of each method (effects on milk yield, protein content and prolactin concentrations) were also noted; it was concluded that IUCDs are the ideal contraceptive method during lactation, with the use of a lactation stimulant when indicated.

Algestone↗
PubMed1981

Postpartum contraception.

Recently-delivered women who wish to avoid pregnancy should initiate contraception before ovulation. Since the return of ovulation is not predictable, regardless of the woman's lactation status and duration of postpartum amenorrhea, contraception should be initiated as soon as is reasonable after delivery. The choice of contraceptive method will depend on several factors, including: the woman's lactation status, the preference of the woman and her partner, and the health status of the newborns. For women who do not wish to have additional children, tubal sterilization through a minilaparotomy incision is the procedure of choice. For other women who are not lactating, all methods, with the exception of the use of cervical caps and diaphragms, may be initiated immediately after delivery. However, preference should be given to IUD use by lactating and non-lactating woman, especially for women who may not return for any additional postpartum care.

Contraception↗
PubMedDate not supplied

Contraceptive decision making in a sample of Jordanian Muslim women: delineating salient beliefs.

In this article, the authors identify attitudes, normative beliefs, and behavioral control beliefs of Muslim Jordanian women with regard to avoiding unplanned pregnancy and using specific contraceptive methods. Based on Ajzen and Fishbein's theory of planned behavior, open-ended questions were used in audio-taped face-to-face interviews with 25 married 19-44-year-old Jordanian Muslim women. A majority of respondents interviewed were currently using an intrauterine device (IUD) for contraception. Few women were using oral contraceptives, condoms, or the rhythm method and none of them reported using foam or a diaphragm. Content analyses of narrative transcriptions suggest the individual's concerns for family and individual well-being, as well as husbands' and families' opinions, may influence women's contraceptive behavior in this population.

Adult↗
PubMed1988

Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome.

Fifteen female adolescents with Down syndrome (DS) and 33 female controls without this syndrome were surveyed on age of menarche, menstruation, sexual relations and contraception. All probands and controls were born between 1 January 1965 and 31 December 1970. The day of census was December 31, 1985. All probands and controls were living permanently in the Danish county of Aarhus on this day. Persons close to the DS patients (parents/foster-parents/permanent staff) were interviewed on the above-mentioned topics. All controls were interviewed themselves. The average age of menarche was 13.6 years for probands and 13.5 years for controls. The average duration of the bleeding was 5.5 days for probands and 5.4 days for controls. The average length of the cycle was 28.3 days for probands and 28.6 days for controls. Thirteen DS patients had not had sexual intercourse (no information was available for 2 probands). Twenty-four controls had and 9 had not had sexual intercourse. There is a significant difference between probands and controls concerning use of oral and other contraceptives.

Adolescent↗
PubMed1984

Results of establishing medical guidelines for selecting oral contraceptive types in family planning agencies.

Family planning agencies are attempting to increase their efficiency and cost-effectiveness in delivering services, as federal funding is diminishing. We have examined the effects of establishing guidelines in a family planning agency, outlining the types of OCs to be routinely prescribed. We found that substantial savings in purchase costs were achieved, in addition to simplified inventory and distribution. These savings were accomplished with no perceptible change in patients' satisfaction. The equivalence of modern OCs in safety and effectiveness allows the creation of guidelines which are medically sound.

Contraceptives, Oral↗
PubMed1989

Risk factors for ovarian cancer: a case-control study.

A hospital-based case-control study of ovarian cancer was conducted in London and Oxford between October 1978 and February 1983. Menstrual characteristics, reproductive and contraceptive history and history of exposure to various environmental factors were compared between 235 women with histologically diagnosed epithelial ovarian cancer and 451 controls. High gravidity, hysterectomy, female sterilisation and oral contraceptive use were associated with a reduced risk of ovarian cancer. Infertility and late age at menopause were associated with an increase in risk. While these factors were related, they were each found to be independently associated with ovarian cancer risk after adjusting for the effect of the other factors.

Adult↗
PubMed1975

Clinical evaluation of a new oral contraceptive, 'Pregnon'.

'Pregnon', a new oral contraceptive containing 1 mg. lynestrenol and 0.05 mg. ethinyl oestradiol, was administered cyclically to 639 women of fertile age over a total of 9,159 cycles. There were no pregnancies. In most cases the withdrawal bleeding resembled normal menstruation. The incidence of metrorrhagia was relatively low and when it did occur it was usually confined to the early treatment cycles and was of very limited duration. The objective and subjective tolerance was excellent.

Adolescent↗